SoWell debuts supplement system for GLP-1 users
SoWell is unveiling GLP-1 Support System, a three-part supplement system designed specifically for GLP-1 users and their side effects.
Alexandra Sowa, board-certified obesity medicine specialist, and forthcoming author of 'The Ozempic Revolution,' developed this product from a decade of GLP-1 research and patient care to specifically meet the unique needs of individuals on a GLP-1 weight loss journey.
Despite 50% of GLP-1 users experiencing side effects, individuals are left to navigate an overwhelming assortment of supplements that are not specifically formulated to their body's new sensitivities or needs, the company said, noting that currently, 1 in 8 Americans are using Ozempic or similar GLP-1 drugs, yet over 70% of users stop taking these life-changing medications within one year largely because of side effects they find too hard to navigate.
[Read more: MegaFood unveils revamped brand identity]
This three-part supplement system is based on the latest clinical research and the founder's decade-long experience working with GLP-1 patients. The SoWell GLP-1 Support System is formulated to target the unique side effects and requirements of GLP-1 users, providing comprehensive support to ensure a sustained and simplified journey on GLP-1 drugs.